This announcement details the progress of LIZHU Group's public tender offer to acquire shares of Imexpharm Corporation (IMP). LIZHU's subsidiary, LIAN SGP, plans to acquire up to 120,059,970 shares, representing approximately 77.94% of IMP's registered capital. The offer price is set at 57,400 VND per share, totaling approximately 15.62 billion RMB. The tender offer period has concluded, and LIAN SGP will proceed with payment and share transfer.
Summary generated by AI · Always verify with source document
Securities Code: 000513, 01513
Securities Abbreviation: LIZHU Group, LIZHU Pharmaceutical
Announcement Number: 2026-38
LIZHU Pharmaceutical Group Co., Ltd. announces the progress of the public tender offer for shares of Vietnam IMP Company. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.